Literature DB >> 10488151

Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13).

J M Manganello1, Y Djellas, C Borg, K Antonakis, G C Le Breton.   

Abstract

Although it is well established that cAMP inhibits platelet activation induced by all agonists, the thromboxane A(2) signal transduction pathway was found to be particularly sensitive to such inhibition. Therefore, we examined whether cAMP-dependent kinase mediates phosphorylation of the thromboxane A(2) receptor-G-protein complex. It was found that cAMP induces protein kinase A-dependent [gamma-(32)P]ATP labeling of solubilized membrane proteins in the region of Galpha subunits, i.e. 38-45 kDa. Moreover, ligand affinity chromatography purification of thromboxane A(2) receptor-G-protein complexes from these membranes revealed that 38-45-kDa phosphoproteins co-purify with thromboxane A(2) receptors. Immunoprecipitation of the affinity column eluate with a Galpha(13) antibody demonstrated that 8-Br-cAMP increased phosphorylation of thromboxane A(2) receptor-associated Galpha(13) by 87 +/- 27%. In separate experiments, immunopurification of Galpha(13) on microtiter wells coated with a different Galpha(13) antibody revealed that 8-Br-cAMP increased Galpha(13) phosphorylation by 53 +/- 19%. Finally, treatment of (32)P-labeled whole platelets with prostacyclin resulted in a 90 +/- 14% increase in phosphorylated Galpha(13) that was abolished by pretreatment with the adenylate cyclase inhibitor MDL-12. These results provide the first evidence that protein kinase A mediates phosphorylation of Galpha(13) both in vitro and in vivo and provides a basis for the preferential inhibition of thromboxane A(2)-mediated signaling in platelets by cAMP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488151     DOI: 10.1074/jbc.274.39.28003

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

2.  Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.

Authors:  M T Walsh; B T Kinsella
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability.

Authors:  M Z Yusuf; Z Raslan; L Atkinson; A Aburima; S G Thomas; K M Naseem; S D J Calaminus
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

4.  PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.

Authors:  A J Unsworth; N Kriek; A P Bye; K Naran; T Sage; G D Flora; J M Gibbins
Journal:  J Thromb Haemost       Date:  2017-02-07       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.